Calciphylaxis in kidney graft recipient with type 1 diabetes: A case report

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Calcifylaxis — calcifying uremic arteriolopathy — is a rare disease that occurs in patients with chronic kidney disease and is characterized by progressive calcification of small-caliber skin vessels and thrombosis of small (arterioles), accompanied by necrosis of the skin, subcutaneous tissue and soft tissues with severe pain syndrome. The article describes a patient with a long-term, severe course of diabetes mellitus, the development of diabetic nephropathy with an outcome in terminal renal failure, which required renal replacement therapy with peritoneal dialysis and kidney transplantation. In the posttransplantation period, the patient registered the occurrence of calcifylaxis, which is a rare complication.

The lack of treatment protocols for calcifylaxis in patients with chronic kidney disease requires further research. It is important to constantly monitor patients with risk factors for the development of this serious disease and timely treatment, which will improve their condition and slow down the progression of the process.

全文:

受限制的访问

作者简介

Valentina Polykova

North-Western State Medical University named after I.I. Mechnikov

Email: valentina.polyakova@szgmu.ru
ORCID iD: 0000-0001-9148-4546

md, cand. sci. (med.), assistant professor

俄罗斯联邦, 41 Kirochnaya St., Saint Petersburg, 191015

Irina Matezius

North-Western State Medical University named after I.I. Mechnikov

Email: imatezius@yandex.ru
ORCID iD: 0000-0002-8694-9756

md, cand. sci. (med.), assistant professor

俄罗斯联邦, 41 Kirochnaya St., Saint Petersburg, 191015

Elizaveta Fomina

North-Western State Medical University named after I.I. Mechnikov

Email: 4891190@mail.ru
ORCID iD: 0009-0002-4905-1573
俄罗斯联邦, 41 Kirochnaya St., Saint Petersburg, 191015

Zakhar Lopatin

North-Western State Medical University named after I.I. Mechnikov

Email: zakhar.lopatin@szgmu.ru
ORCID iD: 0000-0001-7283-9911

md, cand. sci. (med.), assistant professor

俄罗斯联邦, 41 Kirochnaya St., Saint Petersburg, 191015

Elena Semenova

North-Western State Medical University named after I.I. Mechnikov

Email: elenalokb@yandex.ru
ORCID iD: 0000-0003-2955-9097

md, cand. sci. (med.), assistant professor

俄罗斯联邦, 41 Kirochnaya St., Saint Petersburg, 191015

Irina Ulyankina

Academician I.P. Pavlov First St. Petersburg State Medical Universitya; Saint Petersburg Scientific Research Institute of Emergency Medicine named after. I.I. Dzhanelidze

编辑信件的主要联系方式.
Email: spb.yl@mail.ru
ORCID iD: 0000-0001-9207-520X

md, cand. sci. (med.)

俄罗斯联邦, Saint-Petersburg

参考

  1. Podestà MA, Ciceri P, Galassi A, Cozzolino M. Calciphylaxis after kidney transplantation: a rare but life-threatening disorder. Clin Kidney J. 2022;15(4):611–614. doi: 10.1093/ckj/sfab247
  2. Abbas H, Alotaibi M, Lebron R. A case report: Calciphylaxis presenting as digital ischemia in patient with end stage kidney disease on peritoneal dialysis. Open J Nephrol. 2019;9:49–53. doi: 10.4236/ojneph.2019.92006
  3. Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016;27(11):3421–3429. doi: 10.1681/ASN.2015091065
  4. Baby D, Upadhyay M, Joseph MD, et al. Calciphylaxis and its diagnosis. J Family Med Prim Care. 2019;8(9):2763–2767. doi: 10.4103/jfmpc.jfmpc_588_19
  5. Ryan MP, Ross LS. Calciphylaxis after kidney transplant. Cureus. 2019;11(5):e4695. doi: 10.7759/cureus.4695
  6. Gabel CK, Nguyen ED, Chakrala T, et al. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol. 2021;85(4):1057–1064. doi: 10.1016/j.jaad.2020.10.067
  7. Shuman H, Obri MS, Artz C, et al. Nonuremic calciphylaxis precipitated by COVID-19 infection. Cureus. 2022;14(3):e22796. doi: 10.7759/cureus.22796
  8. Nigwekar SU, Kroshinsky D, Nazarian RM, et al. Calciphylaxis: risk factors, diagnosis, and treatmen. Am J Kidney Dis. 2015;66(1):133–146. doi: 10.1053/j.ajkd.2015.01.034
  9. Guillén E, Torregrosa JV, Garcia-Herrera A, et al. Development of calciphylaxis in kidney transplant recipients with a functioning graft. Clin Kidney J. 2021;15(4):663–671. doi: 10.1093/ckj/sfab205
  10. Nefrologiya. Klinicheskie rekomendatsii. Ed. by E.M. Shilov, A.V. Smirnov, N.L. Kozlovskaya. Moscow; 2019. P. 736–740 p. (In Russ.)
  11. Brandenburg V, Adragao T, van Dam B, et al. Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet). Clin Kidney J. 2015;8:567–571. doi: 10.1093/ndt/gfv438
  12. Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016;27:3421–3429. doi: 10.1681/ASN.2015091065
  13. Brandenburg VM, Kramann R, Rothe H, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017;32(1):126–132. doi: 10.1093/ndt/gfv438
  14. Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, et al. Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep. 2018;4(2):231–244. doi: 10.1016/j.ekir.2018.10.002
  15. Kodumudi V, Jeha GM, Mydlo N, Kaye AD. Management of cutaneous calciphylaxis. Adv Ther. 2020;37(12):4797–4807. doi: 10.1007/s12325-020-01504-w
  16. Gaisne R, Péré M, Menoyo V, et al. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study. BMC Nephrol. 2020;21(1):63. doi: 10.1186/s12882-020-01722-y
  17. Jeong HS, Dominguez AR. Calciphylaxis: controversies in pathogenesis, diagnosis and treatment. Am J Med Sci. 2016;351(2):217–227. doi: 10.1016/j.amjms.2015.11.015
  18. Sinha S, Gould LJ, Nigwekar SU, et al. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2022;15:136–144. doi: 10.1093/ckj/sfab117
  19. Ricardo VB, Egido J. Phosphate, pyrophosphate, and vascular calcification: a question of balance. Eur Heart J. 2017;38(23):1801–1804. doi: 10.1093/eurheartj/ehv605
  20. Egshatyan LV, Mokrysheva NG. Ectopic calcification in chronic kidney disease. Part 1. Classification and pathogenesis. Nephrology (Saint-Petersburg). 2017;21(4):30–39. (In Russ.) doi: 10.24884/1561-6274-2017-21-4-30-39
  21. Ruderman I, Toussaint ND, Hawley CM, et al. The Australian calciphylaxis registry: reporting clinical features and outcomes of patients with calciphylaxis. Nephrol Dial Transplant. 2021;36:649–656. doi: 10.1093/ndt/gfz256
  22. Musso CG, Enz PA, Kowalczuk A, et al. Differential diagnosis of calciphylaxis in chronic dialysis patients. Int Urol Nephrol. 2020;52(3):595–597. doi: 10.1007/s11255-020-02388-z
  23. Westphal SG, Plumb T. Calciphylaxis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
  24. Yu WY, Bhutani T, Kornik R, et al. Warfarin-associated nonuremic calciphylaxis. JAMA Dermatol. 2017;153(3):309–314. doi: 10.1001/jamadermatol.2016.4821
  25. Cianciolo G, Capelli I, Angelini ML, et al. Importance of vascular calcification in kidney transplant recipients. Am J Nephrol. 2014;39:418–426. doi: 10.1159/000362492
  26. Ponticelli C, Glassock RJ. Prevention of complications from use of conventional immunosuppressants: a critical review. J Nephrol. 2019;32(6):851–870. doi: 10.1007/s40620-019-00602-5
  27. Guillén E, Torregrosa JV, Garcia-Herrera A, et al. Development of calciphylaxis in kidney transplant recipients with a functioning graft. Clin Kidney J. 2022;15(4):663–671. doi: 10.1093/ckj/sfab205

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Patient E. Necrosis in the area of the terminal phalanx of the IV finger of the right hand

下载 (70KB)
索引源数据
3. Fig. 2. Patient E. X-ray of the hands (vascular calcification)

下载 (66KB)
索引源数据

版权所有 © Eco-Vector, 2023


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.


##common.cookie##